Healthcare provider profile · identity verified

Jacqueline L Hampton, MD

Internal Medicine · MEMPHIS, TN · NPI 1356367452

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	460	177
Amlodipine Besylate	Amlodipine Besylate	433	163
Rosuvastatin Calcium	Rosuvastatin Calcium	340	139
Gabapentin	Gabapentin	328	82
Albuterol Sulfate Hfa	Albuterol Sulfate	270	102
Losartan Potassium	Losartan Potassium	261	102
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	182	64
Furosemide	Furosemide	176	81
Fluticasone Propionate	Fluticasone Propionate	174	76
Pantoprazole Sodium	Pantoprazole Sodium	156	85
Metformin Hcl	Metformin Hcl	147	62
Carvedilol	Carvedilol	146	59
Meloxicam	Meloxicam	131	65
Levothyroxine Sodium	Levothyroxine Sodium	129	42
Glimepiride	Glimepiride	126	45
Duloxetine Hcl	Duloxetine Hcl	125	59
Alendronate Sodium	Alendronate Sodium	118	40
Montelukast Sodium	Montelukast Sodium	118	56
Metoprolol Succinate	Metoprolol Succinate	117	46
Potassium Chloride	Potassium Chloride	111	44
Oxybutynin Chloride Er	Oxybutynin Chloride	110	52
Omeprazole	Omeprazole	108	43
Lisinopril	Lisinopril	103	40
Tamsulosin Hcl	Tamsulosin Hcl	103	41
Hydrochlorothiazide	Hydrochlorothiazide	99	35
Azithromycin	Azithromycin	94	68
Metoprolol Tartrate	Metoprolol Tartrate	86	40
Methylprednisolone	Methylprednisolone	79	60
Trazodone Hcl	Trazodone Hcl	78	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	28
Hydralazine Hcl	Hydralazine Hcl	67	29
Clopidogrel	Clopidogrel Bisulfate	66	29
Linzess	Linaclotide	65	27
Tizanidine Hcl	Tizanidine Hcl	64	33
Baclofen	Baclofen	62	29
Ibuprofen	Ibuprofen	61	39
Diclofenac Sodium	Diclofenac Sodium	59	43
Eliquis	Apixaban	59	19
Pioglitazone Hcl	Pioglitazone Hcl	59	24
Ondansetron Odt	Ondansetron	56	47
Glipizide	Glipizide	52	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	19
Allopurinol	Allopurinol	49	19
Famotidine	Famotidine	48	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	46	14
Citalopram Hbr	Citalopram Hydrobromide	46	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	18
Metformin Hcl Er	Metformin Hcl	45	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	21
Triamcinolone Acetonide	Triamcinolone Acetonide	42	27
Donepezil Hcl	Donepezil Hcl	40	17
Tramadol Hcl	Tramadol Hcl	39	16
Amitriptyline Hcl	Amitriptyline Hcl	38	17
Celecoxib	Celecoxib	37	20
Spironolactone	Spironolactone	37	17
Vitamin D2	Ergocalciferol (Vitamin D2)	37	14
Doxycycline Monohydrate	Doxycycline Monohydrate	36	35
Prednisone	Prednisone	34	23
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Cilostazol	Cilostazol	28	12
Chlorthalidone	Chlorthalidone	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	11
Clonidine Hcl	Clonidine Hcl	24	12
Levofloxacin	Levofloxacin	24	24
Fluconazole	Fluconazole	23	15
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Simvastatin	Simvastatin	23	11
Benazepril Hcl	Benazepril Hcl	22	11
Cephalexin	Cephalexin	22	21
Finasteride	Finasteride	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Colchicine	Colchicine	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Lactulose	Lactulose	21	13
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Valsartan	Valsartan	21	suppressed
Ezetimibe	Ezetimibe	20	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	14
Paxlovid	Nirmatrelvir/Ritonavir	20	19
Sertraline Hcl	Sertraline Hcl	20	suppressed
Naproxen	Naproxen	19	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	13
Amoxicillin	Amoxicillin	17	14
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	15
Lorazepam	Lorazepam	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Atenolol	Atenolol	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error